ArticleMolecules (Basel, Switzerland)2023
Design, Synthesis and Biological Evaluation of Novel PEG-Rakicidin B1 Hybrid as
Lijun Xie, Li Chen, Yongbo Wei, Nannan Chen, Tong Wu, Jingming Zhou, Hong Jiang, Feng Lin
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Lijun XieFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.ORCID 0000-0002-6503-6587 Li ChenFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.
Yongbo WeiFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.
Nannan ChenFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.
Tong WuFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.
Jingming ZhouFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.
Hong JiangFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.ORCID 0000-0002-5753-4930 Feng LinFujian Provincial Key Laboratory of Screening for Novel Microbial Proucts, Fujian Institute of Microbiology, Fuzhou 350007, China.
Funding
Natural Science Foundation of Fujian Province 2020J06028Provincial Science and Technology Special Project 2021R1005006Provincial Science and Technology Special Project 2022R1005006the central government for guiding and supporting local scientific and technological development 2020L3016the central government for guiding and supporting local scientific and technological development 2021L3016
6 · The paper itselfAbstract
Rakicidin B1 was isolated and purified from the culture broth of a marine
Indexed as
Anti-Bacterial AgentsClostridioides difficileAnimalsCaco-2 CellsDepsipeptidesHumansLipopeptidesVancomycinZebrafishAnti-Bacterial AgentsDepsipeptidesLipopeptidesrakicidinsVancomycinanti-Clostridium difficilelow cytotoxicityPEGylation strategyRakicidin B1
Identifiers
PMID37630404
PMCPMC10457740
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390